GlassScriptPhysician profile
Larrah E Jenkins
NPI 1831514306
$362.91
in general payments reported to CMS, 2019-2025
10 companies · $13.94 in 2025
The $13.94 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.13 · 2022: $334 · 2025: $13.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.94.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $84.79 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.89 | 2022 | |
| United Therapeutics Corporation | $35.75 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $32.49 | 2022 | |
| Philips North America LLC | $30.11 | 2022 | |
| Glaxosmithkline, LLC. | $29.91 | 2022 | |
| La Jolla Pharmaceutical Company | $23.83 | 2022 | |
| Ani Pharmaceuticals, INC. | $22.07 | 2022 | |
| Abbvie INC. | $15.13 | 2021 | |
| Abiomed | $13.94 | 2025 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Larrah Jenkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.